Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing NaN - NaN of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Carcinoma, Hepatocellular Trial in China (Amivantamab)

Recruiting
  • Carcinoma, Hepatocellular
  • Beijing, China
  • +15 more
Jan 27, 2023

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +138 more
Aug 22, 2022

Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer Trial in China (Sitravatinib, Sitravatinib plus

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Gastric/Gastroesophageal Junction Cancer
  • Hefei, Anhui, China
  • +17 more
Jul 28, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +40 more
Mar 3, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766), Sorafenib (BAY43-9006))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Sorafenib (BAY43-9006)
  • Louisville, Kentucky
  • +78 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Regorafenib (Stivarga, BAY73-4506)
  • Placebo
  • Los Angeles, California
  • +146 more
Aug 11, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Erlotinib (Tarceva), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • +2 more
  • San Francisco, California
  • +126 more
May 16, 2019

Carcinoma, Hepatocellular Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Nexavar (Sorafenib, BAY43-9006)
  • Placebo
  • Birmingham, Alabama
  • +198 more
Jul 11, 2018

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • La Jolla, California
  • +106 more
Jul 18, 2017

Carcinoma, Hepatocellular Trial in Beijing (GPC3-CART cells)

Unknown status
  • Carcinoma, Hepatocellular
  • GPC3-CART cells
  • Beijing, China
    302 Military Hospital
Apr 22, 2017

Carcinoma, Hepatocellular Trial in China, Taiwan, Thailand (Capecitabine, Peginterferon alfa-2a)

Completed
  • Carcinoma, Hepatocellular
  • Beijing, China
  • +7 more
Nov 1, 2016

Carcinoma, Hepatocellular Trial in Beijing (IGRT, Capecitabine, Oxaliplatin)

Unknown status
  • Carcinoma, Hepatocellular
  • IGRT
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jan 4, 2016

Carcinoma, Hepatocellular Trial in Beijing (radiotherapy)

Unknown status
  • Carcinoma, Hepatocellular
  • radiotherapy
  • Beijing, China
    WU FAN
Oct 21, 2015

Carcinoma, Hepatocellular Trial in Worldwide (Brivanib, Placebo)

Terminated
  • Carcinoma, Hepatocellular
  • Hefei, Anhui, China
  • +31 more
Sep 23, 2015

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Hefei, Anhui, China
  • +22 more
Mar 26, 2014

Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)

Terminated
Has Results
  • Carcinoma, Hepatocellular
  • Fountain Valley, California
  • +170 more
Dec 7, 2012

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

Terminated
  • Hepatocellular Carcinoma Non-resectable
  • +12 more
  • Beverly Hills, California
  • +162 more
Sep 7, 2012